186 related articles for article (PubMed ID: 30535864)
1. Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.
Xuan Z; Huang J; Gao L; Wang Y; Wang J; Sun Y
Pathol Oncol Res; 2020 Jan; 26(1):541-549. PubMed ID: 30535864
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
[TBL] [Abstract][Full Text] [Related]
3. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.
Wang Y; Xuan Z; Wang B; Zhang D; Zhang C; Wang J; Sun Y
Dig Dis Sci; 2019 Jun; 64(6):1514-1522. PubMed ID: 30560328
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
6. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
7. Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.
Smith E; Tomita Y; Palethorpe HM; Howell S; Nakhjavani M; Townsend AR; Price TJ; Young JP; Hardingham JE
Epigenetics; 2019 Feb; 14(2):158-170. PubMed ID: 30739527
[TBL] [Abstract][Full Text] [Related]
8. Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.
Jägle S; Rönsch K; Timme S; Andrlová H; Bertrand M; Jäger M; Proske A; Schrempp M; Yousaf A; Michoel T; Zeiser R; Werner M; Lassmann S; Hecht A
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4886-91. PubMed ID: 24707046
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
10. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
12. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
[TBL] [Abstract][Full Text] [Related]
13. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
14. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
15. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
16. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
18. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
[TBL] [Abstract][Full Text] [Related]
19. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
20. EphB3 protein is associated with histological grade and FIGO stage in ovarian serous carcinomas.
Gao W; Zhang Q; Wang Y; Wang J; Zhang S
APMIS; 2017 Feb; 125(2):122-127. PubMed ID: 28120491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]